Compounds > erythrosine

erythrosine and tamoxifen

erythrosine has been researched along with tamoxifen in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19902 (16.67)18.7374
1990's1 (8.33)18.2507
2000's4 (33.33)29.6817
2010's5 (41.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ariens, AT; Labruyère, W; Lindeman, J; van Marle, J; van Weeren-Kramer, J1
Fisher, B; Gunduz, N; Saffer, EA; Zheng, S1
Hauser, IA; Jakob, I; Lindemann, B; Thévenod, F1
Huff, JL; Plopper, GE; Rust, WL1
Bloss, R; Bojarski, P; Diehl, H; Engelk, M1
Lin, CH; Lin, PH1
Kajta, M; Lasoń, W; Maćkowiak, M; Wójtowicz, AK1
Bourgea, J; Patten, CJ; Wang, J; Williams, ET; Wong, YN1
Hu, XL; Liu, YY; Mei, L; Tan, GH; Xiong, ZQ; Yin, DM1
Cheng, X; Ho, CS; Katsaras, J; Khadka, NK; Pan, J1
Cheng, SJ; Kuo, YC1
Huang, MD; Liu, JY; Song, MR; Tian, Y; Xue, JP; Ye, HN; Yuan, GK; Zhang, FL; Zhang, ZH1

Other Studies

12 other study(ies) available for erythrosine and tamoxifen

ArticleYear
Estrogen receptors in human breast cancer. I. Specificity of the histochemical localization of estrogen receptors using an estrogen-albumin FITC complex.
    Virchows Archiv. B, Cell pathology including molecular pathology, 1982, Volume: 40, Issue:1

    Topics: Animals; Breast Neoplasms; Cattle; Cell Transformation, Neoplastic; Estrogens; Fluorescein-5-isothiocyanate; Fluoresceins; Frozen Sections; Histocytochemistry; Humans; Nafoxidine; Receptors, Estrogen; Serum Albumin, Bovine; Tamoxifen; Thiocyanates; Time Factors

1982
Fluoresceinated estrone binding by human and mouse breast cancer cells.
    Cancer research, 1982, Volume: 42, Issue:2

    Topics: Adult; Aged; Animals; Binding, Competitive; Biopsy, Needle; Breast Neoplasms; Cell Nucleus; Cytoplasm; Estradiol; Female; Fluoresceins; Fluorescent Dyes; Histocytochemistry; Humans; Liver; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Middle Aged; Radioligand Assay; Receptors, Estrogen; Tamoxifen; Uterus

1982
MDR1 in taste buds of rat vallate papilla: functional, immunohistochemical, and biochemical evidence.
    The American journal of physiology, 1998, Volume: 274, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Connective Tissue Cells; Cyclosporine; Epithelial Cells; Female; Fluoresceins; Fluorescent Dyes; Immunoglobulin G; In Vitro Techniques; Kinetics; Male; Microscopy, Fluorescence; Rats; Rats, Sprague-Dawley; Tamoxifen; Taste Buds; Tongue; Verapamil

1998
Screening assay for promigratory/antimigratory compounds.
    Analytical biochemistry, 2000, Apr-10, Volume: 280, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Drug Screening Assays, Antitumor; Fluoresceins; Fluorescent Dyes; Humans; Neoplasm Metastasis; Propidium; Spectrometry, Fluorescence; Tamoxifen; Triazoles; Tumor Cells, Cultured

2000
Tamoxifen perturbs lipid bilayer order and permeability: comparison of DSC, fluorescence anisotropy, laurdan generalized polarization and carboxyfluorescein leakage studies.
    Biophysical chemistry, 2001, Apr-10, Volume: 90, Issue:2

    Topics: 1,2-Dipalmitoylphosphatidylcholine; 2-Naphthylamine; Calorimetry, Differential Scanning; Cell Membrane Permeability; Diphenylhexatriene; Dose-Response Relationship, Drug; Fluoresceins; Fluorescence Polarization; Laurates; Lipid Bilayers; Tamoxifen; Temperature

2001
Induction of ROS formation, poly(ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells.
    Chemico-biological interactions, 2006, Aug-25, Volume: 162, Issue:2

    Topics: Benzoflavones; Breast Neoplasms; Catalase; Cell Line, Tumor; Cell Survival; Chelating Agents; Cytochrome P-450 Enzyme Inhibitors; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Female; Fluoresceins; Humans; Metyrapone; Molecular Structure; NAD; NADP; Oxidation-Reduction; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Polychlorinated Biphenyls; Reactive Oxygen Species; Tamoxifen

2006
Aryl hydrocarbon receptor-mediated apoptosis of neuronal cells: a possible interaction with estrogen receptor signaling.
    Neuroscience, 2009, Jan-23, Volume: 158, Issue:2

    Topics: Animals; Apoptosis; beta-Naphthoflavone; Caspase 3; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Estrogen Antagonists; Fluoresceins; Hippocampus; L-Lactate Dehydrogenase; Mice; Neocortex; Neurons; Receptors, Aryl Hydrocarbon; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Signal Transduction; Tamoxifen; Time Factors

2009
Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:8

    Topics: Amino Acid Sequence; Animals; Binding Sites; Carboxylesterase; Carboxylic Ester Hydrolases; Cell Line; Fluoresceins; Humans; Insecta; Intestine, Small; Microsomes, Liver; Models, Molecular; Molecular Probe Techniques; Molecular Probes; Molecular Sequence Data; Molecular Structure; Sequence Alignment; Substrate Specificity; Tamoxifen

2011
Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons.
    Nature neuroscience, 2011, Dec-11, Volume: 15, Issue:2

    Topics: Analysis of Variance; Animals; Anticonvulsants; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Diazepam; Disease Models, Animal; Electroencephalography; Enzyme-Linked Immunosorbent Assay; Epilepsy; ErbB Receptors; Estrogen Antagonists; Fluoresceins; Interneurons; Kindling, Neurologic; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscarinic Agonists; Muscarinic Antagonists; Neuregulin-1; Organic Chemicals; Parvalbumins; Pilocarpine; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, ErbB-4; Scopolamine; Tamoxifen; Time Factors; Up-Regulation

2011
Interactions of the anticancer drug tamoxifen with lipid membranes.
    Biophysical journal, 2015, May-19, Volume: 108, Issue:10

    Topics: Absorption, Physicochemical; Antineoplastic Agents; Cell Membrane Permeability; Fluoresceins; Lipid Bilayers; Molecular Dynamics Simulation; Tamoxifen; Unilamellar Liposomes

2015
Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation.
    International journal of pharmaceutics, 2016, Feb-29, Volume: 499, Issue:1-2

    Topics: Antineoplastic Agents; Astrocytes; Blood-Brain Barrier; Brain; Carmustine; Cell Line, Tumor; Delayed-Action Preparations; Drug Delivery Systems; Endothelial Cells; Fluoresceins; Glioblastoma; Humans; Lactoferrin; Lipids; Nanoparticles; Permeability; Tamoxifen

2016
A Molecular Combination of Zinc(II) Phthalocyanine and Tamoxifen Derivative for Dual Targeting Photodynamic Therapy and Hormone Therapy.
    Journal of medicinal chemistry, 2017, 08-10, Volume: 60, Issue:15

    Topics: Aldehydes; Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Estradiol; Fluoresceins; Fluorescent Dyes; Humans; Indoles; Isoindoles; Lysosomes; Mice, Inbred BALB C; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Zinc Compounds

2017